[Immunointervention in newly diagnosed type 1 diabetes]

Dtsch Med Wochenschr. 2006 Dec 8;131(49):2783-8. doi: 10.1055/s-2006-957185.

[Article in German]

Authors

T Kaupper¹, M Walter, A-G Ziegler

Affiliation

¹ Institut für Diabetesforschung, München. prevent.diabetes@lrz.uni-muenchen.de

PMID: 17136660
DOI: 10.1055/s-2006-957185

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Atorvastatin
Autoimmune Diseases / immunology*
Diabetes Mellitus, Type 1 / immunology*
Diabetes Mellitus, Type 1 / prevention & control
Diabetes Mellitus, Type 1 / therapy*
Heptanoic Acids / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use*
Insulin-Secreting Cells / immunology
Insulin-Secreting Cells / pathology
Prediabetic State / immunology*
Prediabetic State / therapy
Pyrroles / therapeutic use

Substances

Antibodies, Monoclonal
Heptanoic Acids
Immunosuppressive Agents
Pyrroles
Atorvastatin